Copyright
©2012 Baishideng Publishing Group Co.
World J Gastrointest Pharmacol Ther. Feb 6, 2012; 3(1): 1-6
Published online Feb 6, 2012. doi: 10.4292/wjgpt.v3.i1.1
Published online Feb 6, 2012. doi: 10.4292/wjgpt.v3.i1.1
Table 3 Helicobacter pylori eradication rates
| Treatment groups | ||||||
| LACM7 | LAC7 | P value | ||||
| Eradication | n | % | n | % | ||
| ITT analysis | Success | 56 | 94.9 | 41 | 68.3 | 0.0002 |
| Failure | 3 | 5.1 | 19 | 31.7 | ||
| Per protocol analysis | Success | 56 | 98.3 | 41 | 73.2 | 0.0001 |
| Failure | 1 | 1.7 | 15 | 26.8 | ||
- Citation: Yanai A, Sakamoto K, Akanuma M, Ogura K, Maeda S. Non-bismuth quadruple therapy for first-line Helicobacter pylori eradication: A randomized study in Japan. World J Gastrointest Pharmacol Ther 2012; 3(1): 1-6
- URL: https://www.wjgnet.com/2150-5349/full/v3/i1/1.htm
- DOI: https://dx.doi.org/10.4292/wjgpt.v3.i1.1